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Familial partial lipodystrophy (FPLD), Dunnigan variety, is an autosomal dominant disorder characterized by
marked loss of subcutaneous adipose tissue from the extremities and trunk but by excess fat deposition in the head
and neck. The disease is frequently associated with profound insulin resistance, dyslipidemia, and diabetes. We
have localized a gene for FPLD to chromosome 1q21-q23, and it has recently been proposed that nuclear lamin
A/C is altered in FPLD, on the basis of a novel missense mutation (R482Q) in five Canadian probands. This gene
had previously been shown to be altered in autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD-AD)
and in dilated cardiomyopathy and conduction-system disease. We examined 15 families with FPLD for mutations
in lamin A/C. Five families harbored the R482Q alteration that segregated with the disease phenotype. Seven
families harbored an R482W alteration, and one family harbored a G465D alteration. All these mutations lie
within exon 8 of the lamin A/C gene—an exon that has also been shown to harbor different missense mutations
that are responsible for EDMD-AD. Mutations could not be detected in lamin A/C in one FPLD family in which
there was linkage to chromosome 1q21-q23. One family with atypical FPLD harbored an R582H alteration in
exon 11 of lamin A. This exon does not comprise part of the lamin C coding region. All mutations in FPLD affect
the globular C-terminal domain of the lamin A/C protein. In contrast, mutations responsible for dilated cardiom-
yopathy and conduction-system disease are observed in the rod domain of the protein. The FPLD mutations R482Q
and R482W occurred on different haplotypes, indicating that they are likely to have arisen more than once.
Introduction
Familial partial lipodystrophy (FPLD), Dunnigan variety
(MIM 151660), is an autosomal dominant disorder
characterized by marked loss of subcutaneous adipose
tissue from the extremities and trunk at puberty and by
predisposition to insulin resistance and its complica-
tions. Affected patients may also have excess fat depo-
sition in the head and neck areas. We have previously
localized FPLD to human chromosome 1q21-q23, with
use of a cohort of five multiply affected families of Eu-
ropean origin (Peters et al. 1998). Two groups (Jackson
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et al. 1998; Anderson et al. 1999) have confirmed this
localization in families from the United Kingdom and
the United States.
Recently, a candidate gene for FPLD was described
(Cao and Hegele 2000). This gene, lamin A/C, encodes
a component of the nuclear lamina, a polymeric struc-
ture intercalated between chromatin and the inner
membrane of the nuclear envelope (Gerace and Blobel
1982). The lamin A/C (LMNA) gene undergoes alter-
native splicing to produce two nuclear laminar proteins:
lamin A and lamin C (Lin and Worman 1993). Lamins
A and C form dimers through their rod domain (Fisher
et al. 1986; McKeon et al. 1986), and they bind and
assemble on the surface of mitotic chromosomes at spe-
cific sites on the rod (Glass and Gerace 1990; Glass et
al. 1993). Lamins A and C also associate with integral
proteins of the nuclear envelope, such as lamin-asso-
ciated polypeptides 1A and 1B (Foisner and Gerace
1993), lamin B receptor (Worman et al. 1990), and
emerin (Squarzoni 1998). The rod domain is flanked by
hydrophobic N- and C-terminal domains (Fisher et al.
1986; McKeon et al. 1986).
Mutations in LMNA have been described in auto-
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somal dominant Emery-Dreifuss muscular dystrophy
(EDMD-AD; Bonne et al. 1999), a disease characterized
by regional and progressive skeletal muscle wasting and
weakness and by cardiac abnormalities. Missense mu-
tations in the rod domain of LMNA have also been
shown to cause dilated cardiomyopathy and conduc-
tion-system disease (Fatkin et al. 1999).
Because we were interested in evaluating the role of
the lamin A/C gene in FPLD, we performed amutational
analysis of affected family members in a cohort of fam-
ilies with the disease. We detected four independent mu-
tations in members of 14 families. One mutation has
been described elsewhere (Cao and Hegele 2000). The
other three have not previously been reported. Twomu-
tations affected the same codon and were seen on a
variety of different haplotypes, indicating that they are
likely to be recurrent mutations. All the alterations oc-
cur in the globular C-terminal portion of the protein,
and none of the alterations occur in the rod domain of
lamin A/C, unlike the dilated cardiomyopathy and con-
duction-system-disease defects that are clustered in this
region. The region harboring FPLD mutations also har-
bors different missense alterations that are responsible
for EDMD-AD. One FPLD alteration occurs in exon
11 and affects lamin A only.
Families and Methods
Sample Collection
Five families with FPLD have been described else-
where (Peters et al. 1998). Pedigrees of the additional
10 families are shown in figure 1. All families were re-
cruited through the referral of an affected female as an
index case. All families were of European origin, except
for family F2600, which was of Asian Indian origin (ta-
ble 1). The protocol was approved by the appropriate
institutional review boards, and all subjects gave in-
formed consent. The phenotype was classified as “af-
fected,” “unaffected,” or “uncertain,” on the basis of
history, physical examination, review of the medical re-
cords, responses to a written questionnaire, and inspec-
tion of photographs (when available). Lack of subcu-
taneous fat and extreme muscularity in all extremities,
commencing at puberty, was considered the essential cri-
terion for diagnosis. Another important diagnostic cri-
terion was excess fat accumulation in the face and neck,
which resulted in a cushingoid appearance. Additional
supportive criteria included (1) the presence of acan-
thosis nigricans or hirsutism and (2) laboratory data
confirming the presence of diabetes mellitus, hypertrig-
lyceridemia, or low serum levels of HDL cholesterol. In
some patients, characteristic body-fat distribution, as
seen on whole-body magnetic-resonance images, pro-
vided confirmation of the diagnosis (Garg et al. 1999).
Determination of the phenotypewas easily accomplished
in women, but, in some men and prepubertal children,
it was classified as “uncertain.” Lymphoblastoid cell
lines were established by Epstein-Barr–virus transfor-
mation of peripheral blood lymphocytes, and genomic
DNA was isolated either from these cells or buffy coat,
by use of routine methods.
Clinical Features
In all families, affected subjects—particularly, affected
women—had an increased frequency of hypertriglycer-
idemia, low levels of serum HDL cholesterol, and dia-
betes mellitus (with age at onset primarily at 120 years).
Some patients had eruptive xanthomas and recurrent
episodes of acute pancreatitis as a result of extreme hy-
pertriglyceridemia. Other manifestations in affected sub-
jects included acanthosis nigricans, hypertension, and
atherosclerotic vascular disease, including coronary
heart disease. Some affected women had irregular men-
strual periods, hirsutism, and polycystic ovarian syn-
drome. The proband from family F100 complained of
myopathy, but the clinical features were not similar to
those seen in patients with EDMD-AD.
Genotyping and Haplotype Reconstruction
DNA from family members was subjected to semi-
automated genotyping of polymorphic microsatellites
from the FPLD interval. Genotyping methods are de-
scribed elsewhere (Bennett et al. 2000). Haplotypes were
reconstructed by means of the computer software CY-
RILLIC and were verified by eye.
Mutational Analysis of Lamin A/C
Primers that would amplify each exon of the lamin
A/C gene from genomic DNA templates were designed
from published sequence information (Lin and Worman
1993; GenBank accession numbers L12399, L12400
and L12401). PCR products for each exon from each
individual were subjected to analysis by means of
denaturing high-performance liquid chromatography
(DHPLC) (Underhill et al. 1997). DHPLC was per-
formed with use of the “Wave” (Transgenomic). Prod-
ucts were eluted with a linear acetonitrile (J. T. Baker)
gradient at a flow rate of 0.9 ml/min. The beginning and
end points of the gradient were adjusted according to
the size of the PCR products. Generally, analysis took
!10 min, including column regeneration and reequili-
bration of the starting conditions. Samples that exhibited
DHPLC variants were DNA sequenced with use of the
Big Dye Terminator Cycle Sequencing Ready Reaction
sequencing kit (PE Biosystems), and reactions were an-
alyzed with the use of an ABI PRISM 377 DNA
sequencer.
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Figure 1 Pedigrees of families with FPLD, Dunnigan variety. The pedigrees and each family member are numbered for identification.
Unblackened squares denote unaffected males; blackened squares, affected males; unblackened circles, unaffected females; blackened circles,
affected females; circles and squares with a diagonal slash, deceased subjects; gray-shaded circles and squares, phenotype uncertain. Vertical
arrows denote subjects for which DNA was available, whereas slanting arrows indicate probands from each family.
Results
Haplotype Reconstruction
Haplotypes segregating with disease in each family
are listed in table 1; they correspond to alleles from
the following polymorphic satellite–containing loci:
D1S305, D1S303, D1S1595, D1S2140, D1S2777,
D1S2624, and D1S1600. Most haplotypes were very
different, although some harbored the same mutation in
lamin A/C. Families F2500 and F200 may harbor a core
“6, 1, 4” haplotype at D1S2140, D1S2777, and
D1S2624.
Mutational Analysis
Table 1 describes the lamin A/C mutations detected
in the families studied. In families F200, F500, F1000,
F2500, and F3300, the previously described R482Q
(CGGrCAG) alteration in exon 8 (Cao and Hegele
2000) was detected. Seven families—F300, F600, F700,
F900, F1400, F2600, and 2900—harbored a different
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Table 1
Lamin A/C Mutations and Haplotypes Segregating with Disease in Families with FPLD
FAMILY
HAPLOTYPES CORRESPONDING TO LOCI ANALYZED
MUTATION
DETECTEDD1S305 D1S303 D1S1595 D1S2140 D1S2777 D1S2624 D1S1600
F100 2 4 3 4 7 2 4 NDa
F200 5 1 5 6 1 4 4 R482Q
F500 1 1 4 6 1 2 6 R482Q
F1000 5 1 5 6 5 2 3 R482Q
F2500 5 1 7 6 1 4 3 R482Q
F3300 1 1 5 6 1 1 3 R482Q
F300 6 1 11 2 1 5 4 R482W
F600 1 1 5 6 5 2 4 R482W
F700 2 1 5 6 1 1 4 R482W
F900 1 4 11 2 9 2 4 R482W
F1400 6 4 5 6 2 4 3 R482W
F2600 5 1 7 7 5 1 3 R482W
F2900 8 1 3 4 1 1 or 2 5 R482W
F2700 2 1 5 6 1 1 4 R582H
F1100 2 1 5 6 1 1 3 G465D
NOTE.—All families are of European origin, with the exception of family F2600, which is of Asian Indian
origin. D1S305 is the most centromeric locus. The most-likely location of FPLD is between D1S305 and
D1S2624 (Peters et al. 1998). The most-likely location of lamin A/C is between D1S2777 and D1S2624
(unpublished observations).
a ND = none detected.
alteration R482W (CGGrTGG) in the same codon.One
family (F1100) harbored a G465D (GGCrGAC) alter-
ation. In the affected members of all families, the variant
allele segregated with disease. We were unable to detect
mutations in lamin A/C in affected members of family
F100, in which there was linkage. None of these variants
were seen in more than 140 normal chromosomes from
CEPH.
One family with atypical FPLD (F2700) harbored a
novel R582H (CGCrCAC) alteration within exon 11
of the lamin A/C gene. Sequences encoded by this exon
are found in the lamin A mRNA only.
We detected two polymorphisms that resulted in silent
changes: one in exon 5 (GCTrGCC; codon 297) and
one in exon 7 (GATrGAC; codon 446). These were also
seen in several expressed sequence tag clones. Chro-
mosomes from one unaffected CEPH individual (indi-
vidual 1701) harbored an R633C (CGCrTGC) altera-
tion in exon 11 of lamin A. This change was not seen
in 139 other normal chromosomes from CEPH and is
likely to be a rare variant that is unrelated to the diseases
described in the present study.
Discussion
Fifteen families with FPLD were examined for molecular
alterations in the lamin A/C gene on human chromo-
some 1q21. Four alterations were detected—threewithin
exon 8 and one within exon 11. One mutation, R482Q,
was seen in five of the families in the present study and
was first described in five probands from Canada (Cao
and Hegele 2000). One of the families in the present
study is also of Canadian origin and could be related to
one of the kindreds described elsewhere (Cao andHegele
2000); however, it could reflect an earlier founder effect.
The other three mutations have not previously been
described. Two alterations—R482Q and R482W—
disrupted the same codon and were seen on a variety of
different haplotypes, indicating that they are likely to be
recurrent mutations. To date, all families with FPLD
described in the literature have been of European origin
(Garg 2000). However, one of the families (family
F2600) in the present study is of Asian Indian origin.
This family harbored the most frequently observed mu-
tation, R482W, on a novel haplotype.
Both the R482Q and the R482W mutations occur
within a stretch of CCGG nucleotides and result in a
CTGG change. Of the mammalian DNA, 2%–7% is
converted to 5-methylcytosine (Vanyushin et al. 1970),
and 190% of the 5-methylcytosine residues in the DNA
of higher eukaryotes are bordered by a G residue on
the 3′ side (Doskocil and Sorm 1962; Grippo et al.
1968). Ehrlich and Wang (1981) propose that 5-meth-
ylcytosine can be mutated to thymidine via deamination
and mismatch repair. The observation that both the
R482Q and R482W mutations occur on several differ-
ent haplotypes suggests that they have arisen more than
once, possibly by means of the mechanism described
above.
The third alteration found within exon 8 is a G465D
change. The fourth alteration, R582H, occurred within
exon 11 of the lamin A/C gene and can affect the lamin
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Figure 2 Amino-acid-sequence alignment of lamins A, B, and C
from various species. A, Conservation of Gly465 and Arg482 of lamin
A/C is shown in boldface type. B, Conservation of Arg582 of lamin
A is shown in boldface type. Xenopus = Xenopus laevis.
A protein only. In FPLD, all missense mutations iden-
tified in exons 8 and 11 change amino acids conserved
through different species and in different lamins (fig. 2).
DHPLC and sequencing analysis failed to reveal a
mutation within the lamin A/C coding sequence inmem-
bers of family F100, in which linkage to chromosome
1q21 was found. Mutational analyses of the regulatory
elements of this gene—as well as Southern blotting to
detect large rearrangements—are required to rule out
alterations in other regions.
The distribution, within lamin A/C, of mutations that
are responsible for three different diseases—EDMD-
AD, dilated cardiomyopathy and conduction-system
disease, and FPLD—are illustrated in figure 3. The
lamin A/C gene is encoded by 12 exons, and alternative
splicing within exon 10 gives rise to the two isoforms
(Lin and Worman 1993). The first 566 amino acids of
lamins A and C are identical. Lamin C contains 6 ad-
ditional C-terminal amino acids, and lamin A contains
128 additional C-terminal amino acids. Pre–lamin A
peptide undergoes farnesylation at the peptide sequence
CAAX within the C-terminal and is cleaved to lamin A
(Sinensky et al. 1994).
All of the alterations in FPLD occur in the globular
C-terminal portion of the lamin A/C protein, and none
of the alterations occur in the a-helical rod domain,
unlike the dilated cardiomyopathy and conduction-sys-
tem-disease defects that are clustered in this region (Fat-
kin et al. 1999). Only one mutation causing dilated
cardiomyopathy and conduction-system disease occurs
in the lamin C tail domain. In contrast, missense mu-
tations in the hydrophobic C-terminal region of lamin
A/C result in EDMD-AD (Bonne et al. 1999). One case
of EDMD-AD is the result of a nonsense mutation
within codon 6 of the protein. However, this may result
in loss of the protein entirely, because of nonsense-me-
diated RNA degradation, or it may result in a non-
functional, highly truncated protein. It is interesting that
three FPLD mutations cluster in exon 8, a region that
also harbors EDMD-AD changes. The overlap between
FPLD and EDMD-AD changes is interesting, since
FPLD and EDMD-AD appear to affect different devel-
opmental processes. FPLD appears to affect adipocyte
apoptosis or differentiation, and EDMD-AD changes
result in regional and progressive skeletal muscle wast-
ing and cardiac abnormalities.
The observation that one FPLD mutation occurs
within the C-terminal region of lamin A (R582H; exon
11) contrasts with a single missense mutation within the
C-terminal of lamin C in dilated cardiomyopathy and
conduction-system disease. In two affected sisters that
underwent clinical evaluation and that were from the
family that harbors this mutation, reduction in subcu-
taneous fat from both the gluteal region and the medial
aspects of the thighs was less pronounced, compared
with that in other women with FPLD. One of these
sisters had diabetes mellitus, borderline hypertriglycer-
idemia, and irregular menstrual periods, but the other
had normal glucose tolerance, normal serum lipids, and
regular menstrual periods. Neither sister had acanthosis
nigricans. However, this type of clinical heterogeneity
is seen in other families with FPLD; ∼50% of affected
women have diabetes mellitus, and only one-third have
irregular periods and acanthosis nigricans. The R582H
alteration may disrupt some interactions of lamin A
with chromatin, since it has been shown that carboxy-
terminal sequence elements of lamin A are required for
the observed lamin-chromatin interaction (Hoger et al.
1991).
The results of the present study confirm and extend
findings from a previous report (Cao and Hegele 2000)
indicating that missense mutations in the lamin A/C
gene cosegregate with FPLD. However, it is not clear
how the alterations described in the present study lead
to adipocyte apoptosis or initiate loss of fat at puberty.
Additional studies are also required to determine why
different alterations within lamin A/C are responsible
for three clinically distinct diseases.
Note added in proof.—Recently, Shackleton et al.
(2000) also confirmed the findings of Cao and Hegele
(2000) and reported missense mutations limited to exon
8 in ten families and three individuals with FPLD (Dun-
nigan variety). They also observed the R482Q and
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Figure 3 Locations of mutations in lamin A/C in EDMD-AD (squares), dilated cardiomyopathy with conduction-system-disease defects
(ovals), and FPLD (diamonds). Organization of the proteins is also indicated, and locations of the hydrophobic head and carboxy-terminal
regions, with respect to the rod domain, are shown. The regions of lamin A and C that diverge from each other are indicated at the carboxyl-
termini.
R482W mutations and report novel R482L and K486N
mutations.
Acknowledgments
We thank the members of the families studied, for their
invaluable contribution to this project; Drs. David C. Robbins,
Robert A. Kreisberg, Andrea Dunaif, Richard Legro, Mark D.
Shepherd, Irene Sills, Margo Denke, Steven Aronoff, Noralane
M. Lindor, Tu T. Nguyen, and Evelyn Cintron, for referring
family members for investigation; Angela Osborn and Rebecca
Cochran, for technical help; and the nursing and dietetic serv-
ices of the General Clinical Research Center, for patient care
support. This work was supported by National Institutes of
Health grants R01-DK54387 and M01-RR00633, the South-
western Medical Foundation, and the Washington University
Medical Center Division of Human Genetics.
Electronic-Database Information




(for human nuclear lamin A and nuclear lamin C gene, exon
1 [accession number L12399]; human nuclear lamin A and
nuclear lamin C gene, exon 2 [accession number L12400];
and human nuclear lamin A and nuclear lamin C gene, exons
3–12, and complete alternative mRNAs [accession number
L12401])
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for FPLD [MIM 151660])
References
Anderson JL, Khan M, David WS, Mahdavi Z, Nuttall FQ,
Krech E, West SG, et al (1999) Confirmation of linkage of
hereditary partial lipodystrophy to chromosome 1q21-22.
Am J Med Genet 82:161–165
Bennett LB, Roach SE, Bowcock AM (2000) A locus for par-
oxysmal kinesigenic dyskinesia maps to human chromosome
16. Neurology 54:125–130
Bonne G, Di BarlettaMR, Varnous S, BecaneHM,Hammouda
EH, Merlini L, Muntoni F, et al (1999) Mutations in the
gene encoding lamin A/C cause autosomal dominant Emery-
Dreifuss muscular dystrophy. Nat Genet 21:285–288
CaoH, Hegele RA (2000) Nuclear lamin A/CR482Qmutation
in Canadian kindreds with Dunnigan-type familial partial
lipodystrophy. Hum Mol Genet 9:109–112
Doskocil J, Sorm F (1962) Distribution of 5-methylcytosine in
pyrimidine sequences of deoxyribonucleic acids. Biochim
Biophys Acta 55:953–959
Ehrlich M, Wang RYH (1981) 5-Methylcytosine in eukaryotic
DNA. Science 212:1350–1357
Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Fren-
neaux M, Atherton J, et al (1999) Missense mutations in
the rod domain of the lamin A/C gene as causes of dilated
cardiomyopathy and conduction-system disease. N Engl J
Med 341:1715–1724
Fisher DZ, Chaudhary N, Blobel G (1986) cDNA sequencing
of nuclear lamins A and C reveals primary and secondary
structural homology to intermediate filament proteins. Proc
Natl Acad Sci USA 83:6450–6454
Foisner R, Gerace L (1993) Integral membrane proteins of the
nuclear envelope interact with lamins and chromosomes,
and binding is modulated by mitotic phosphorylation. Cell
73:1267–1279
1198 Am. J. Hum. Genet. 66:1192–1198, 2000
Garg A (2000) Lipodystrophies. Am J Med 108:143–152
Garg A, Peshock RM, Fleckenstein JL (1999) Adipose tissue
distribution pattern in patients with familial partial lipod-
ystrophy (Dunnigan variety). J Clin Endocrinol Metab 84:
170–174
Gerace L, Blobel G (1982) Nuclear lamina and the structural
organization of the nuclear envelope. Cold Spring Harb
Symp Quant Biol 46:967–978
Glass JR, Gerace L (1990) Lamins A and C bind and assemble
at the surface of mitotic chromosomes. J Cell Biol 111:
1047–1057
Glass CA, Glass JR, Taniura H, Hasel KW, Blevitt JM, Gerace
L (1993) The a-helical rod domain of human lamins A and
C contains a chromatin binding site. EMBO J 12:4413–4424
Grippo P, LaccarinoM, Paris E, Scarono E (1968)Methylation
of DNA in developing sea urchin embryos. J Mol Biol 36:
195–208
Hoger TH, Krohne G, Kleinschmidt JA (1991) Interaction of
Xenopus lamins A and LII with chromatin in vitro mediated
by a sequence element in the carboxyterminal domain. Exp
Cell Res 197:280–289
Jackson SNJ, Pinkney J, Bargiotta A, Veal CD, Howlett TA,
McNally PG, Corral R, et al (1998) A defect in the regional
deposition of adipose tissue (partial lipodystrophy) is en-
coded by a gene at chromosome 1q. Am J Hum Genet 63:
534–540
Lin F, Worman HJ (1993) Structural organization of the hu-
man gene encoding nuclear lamin A and nuclear lamin C.
J Biol Chem 268:16321–16326
McKeon FD, Kirschner MW, Caput D (1986) Homologies
in both primary and secondary structure between nuclear
envelope and intermediate filament proteins. Nature 319:
463–469
Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM,
Garg A (1998) Localization of the gene for familial partial
lipodystrophy (Dunnigan variety) to chromosome 1q21-22.
Nat Genet 18:292–295
Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF,
Singh BM, Schmidt H, et al (2000) LMNA, encoding lamin
A/C, is mutated in partial lipodystrophy. Nature Genet 24:
153–156
Sinensky M, Fantle K, Trujillo M, McLain T, Kupfer A, Dalton
M (1994) The processing pathway of prelamin A. J Cell Sci
107:61–67
Squarzoni S (1998) Immunocytochemical detection of emerin
within the nuclear matrix. Neuromuscul Disord 8:338–344
Underhill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath
D, Davis RW, et al (1997) Detection of numerous Y chro-
mosome biallelic polymorphisms by denaturing high-per-
formance liquid chromatography. Genome Res 7:996–1005
Vanyushin BF, Tkacheva SG, Belozersky AN (1970) Rare bases
in animal DNA. Nature 225:948–949
Worman HJ, Evans CD, Blobel G (1990) The lamin B receptor
of the nuclear envelope inner membrane: a polytopic protein
with eight potential transmembrane domains. J Cell Biol
111:1535–1542
